Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2023-12-20
2025-02-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dementia Symptom Management at Home Program
NCT03255967
Cognitive Intervention For Delirium in Dementia
NCT01267682
Improving How People Living With Dementia Are Selected for Care Coordination
NCT05651308
The Dementia Symptom Management at Home Program
NCT02482623
Innovations in Dementia Empowerment and Action
NCT03550131
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Family Caregivers of PLWD at High Risk for Delirium
Participants will complete the Aliviado DSD Caregiving Mastery Program. This involves a caregiver education/training period from Week 0 to Week 2, and an implementation period from Week 3 to Week 6.
Aliviado DSD Caregiving Mastery Program
Family caregiver intervention consisting of mHealth-app based educational videos and articles; caregiver-administered assessment tools and care plans; and motivational push notification reminders and encouragements.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Aliviado DSD Caregiving Mastery Program
Family caregiver intervention consisting of mHealth-app based educational videos and articles; caregiver-administered assessment tools and care plans; and motivational push notification reminders and encouragements.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* be at least 18 years old,
* be English-speaking,
* provide at least 8 hours of unpaid care weekly or live with a community-dwelling PLWD,
* self-identify as unfamiliar with DSD,
* have the capacity to consent, and
* have Internet access
To be eligible as a "DSD caregiver" in the co-design workshop, an individual must:
* be at least 18 years old,
* be English-speaking,
* be a current or past dementia caregiver with experience caring for a relative or friend during his/her DSD episode within the past 12 months,
* have the capacity to consent, and
* have Internet access.
To be eligible to participate in the feasibility trial, an individual must meet all of the following criteria:
* Being 18 years old or older,
* English-speaking,
* Providing at least 8 hours of unpaid care per week to, or living with, a community dwelling PLWD whose Delirium Risk Assessment Score \>=5,
* Having the capacity to give informed consent, and
* Having a smartphone with Internet access.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shih-Yin Lin
Role: PRINCIPAL_INVESTIGATOR
NYU Rory Meyers College of Nursing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Langone Health
New York, New York, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-01093
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.